(Rye Brook, NY – May 2, 2017) – The rising cost of treatment and care for blood cancer patients has reached a boiling point, according to The Leukemia & Lymphoma Society (LLS), with an increasing number of patients foregoing their medications or reducing the dosage or frequency of their doctor‐prescribed treatments solely for cost reasons. In 2016, LLS’s free Information Resource Center received more than...
Two-time Olympic gold medalist and world record holder in Decathlon Ashton Eaton and 2016 Rio Olympic bronze medalist in Heptathlon Brianne Theisen-Eaton team up with LLS to fight cancer View full multimedia release here. RYE BROOK, N.Y. (April 11, 2017) – The world’s first and foremost sports endurance training program for charity, Team In Training, is teaming up with Olympic track and field st...
Rye Brook, NY (April 5, 2017) - The Leukemia & Lymphoma Society (LLS) continues to advance the promising field of immunotherapy research, harnessing the body’s own immune system to fight cancer, with a $4 million funding commitment in an investigational therapy being developed by Forty Seven Inc. for lymphoma patients. There are approximately 630,000 patients in the United States living with non-Hodgkin lymp...
Washington, D.C. and Rye Brook, NY (March 23, 2017) –The Leukemia & Lymphoma Society (LLS) together with the National Black Church Initiative (NBCI) announce the launch of a church-based initiative addressing striking health disparities among African Americans with multiple myeloma. Black Americans have twice the incidence of multiple myeloma as white Americans, and recent studies show black Americans are signi...
March 22, 2017 (Rye Brook, NY) – As the world’s leading non-profit dedicated to fighting blood cancers, The Leukemia & Lymphoma Society (LLS) has played a role in most therapies used today to treat blood cancer patients, some of which are even helping patients with other cancers and serious diseases. Such advances are possible due to LLS’s significant investment in cutting-edge research – more t...
The Leukemia & Lymphoma Society (LLS) firmly opposes the Administration’s proposed budget, which reduces the funding for the National Institutes of Health (NIH) by $5.8 billion. These cuts risk derailing decades of advancement in the diagnosis, understanding and treatment of deadly blood cancers. LLS is calling upon members of Congress to reject these proposed cuts and increase funding for the NIH in future app...
Rye Brook, NY, March 17, 2017 – The adage says, “It’s not the titles that honor men, but the men who honor titles.” This could not be more accurate for the 900 men and women across the United States vying to win The Leukemia & Lymphoma Society’s (LLS) coveted title, Man & Woman of the Year (MWOY), conferred at the conclusion of this annual campaign. For 10 weeks, in 80 communities across the co...
Rye Brook, N.Y. (March 16, 2017) – The Leukemia & Lymphoma Society (LLS), the world’s largest voluntary health agency dedicated to fighting blood cancer, announced it has appointed Gwen Nichols, M.D., chief medical officer (CMO). A physician and scientific researcher, Nichols has dedicated her career to advancing cures for cancers through a unique combination of clinical, academic and pharmaceut...
Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday: